ESCRS - Getting and maintaining a large pupil ;
ESCRS - Getting and maintaining a large pupil ;

Getting and maintaining a large pupil

Intracameral mydriasis (ICM) provides very rapid mydriasis and can also help stop iris haemorrhage

Getting and maintaining a large pupil
Leigh Spielberg
Leigh Spielberg
Published: Friday, October 13, 2017
“Changing Pharmaceutical Treatment Patterns in Cataract Surgery” was the topic of the Main Symposium at the 2017 annual meeting of ESCRS in Lisbon on Sunday. Conceição Lobo, Coimbra University Hospital, Portugal, updated delegates regarding the best ways to achieve and maintain a large pupil during cataract surgery. “Intracameral mydriasis (ICM) provides very rapid mydriasis and can also help stop iris haemorrhage, due to the vasoconstrictive effects,” said Dr Lobo. Dr Lobo reported that randomised clinical trials have shown that the intracameral combination of phenylephrine 2.5% + tropicamide 1% is equally safe and more effective than lower concentrations. The recommended concentration for adrenaline is 1:1,000,000, due to its potential for endothelial toxicity. Other possibilities are Mydriasert inserts (phenylephrine 5.4mg + tropicamide 0.26mg) for the inferior fornix and Mydrane (phenylephrine + tropicamide + lidocaine), both from Théa Laboratoires. Dr Lobo also offered some tips for the preoperative evaluation. “Eyes with a pre-op dilated pupil diameter of 7.0mm or smaller are at risk for IFIS, regardless of alpha-1 antagonist treatment history,” she said. In these patients, more extensive precautions, either preoperatively or during surgery, might help avoid pupillary problems that could lead to complications. If pharmacologic means are insufficient to achieve or maintain adequate mydriasis, mechanical means such as pupillary expanders or viscoelastic devices (OVD) must be used. “A combination of a viscoadaptive OCD, which mechanically stretches the pupil, and a dispersive OVD, which resists aspiration, can maintain mydriasis for the duration of surgery.”
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;